CD33 Expression on Peripheral Blood Monocytes Predicts Efficacy of Anti-PD-1 Immunotherapy Against Non-Small Cell Lung Cancer

Non-small cell lung carcinoma (NSCLC) is the leading cause of cancer-related deaths globally. Immune checkpoint blockade (ICB) has transformed cancer medicine, with anti-programmed cell death protein 1 (anti-PD-1) therapy now well-utilized for treating NSCLC. Still, not all patients with NSCLC respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Olingy, Claire, Alimadadi, Ahmad, Araujo, Daniel J., Barry, David, Gutierrez, Norma A., Werbin, Max Hardy, Arriola, Edurne, Patel, Sandip Pravin, Ottensmeier, Christian H., Dinh, Huy Q., Hedrick, Catherine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046782/
https://www.ncbi.nlm.nih.gov/pubmed/35493454
http://dx.doi.org/10.3389/fimmu.2022.842653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046782/
https://www.ncbi.nlm.nih.gov/pubmed/35493454
http://dx.doi.org/10.3389/fimmu.2022.842653

Ejemplares similares